Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-08-25 00:00:00 ET · period of report 2023-08-23 · accession 0001579587-23-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-25 | 2023-08-23 | ANIP | Marken James G. | SVP OPS, PROD DEV | M - OptEx | $38.25 | +5,417 | 135.4K | +4% | +$207.2K |
| D | 2023-08-25 | 2023-08-23 | ANIP | Marken James G. | SVP OPS, PROD DEV | S - Sale+OE | $63.00 | -3,932 | 133.1K | -3% | -$247.7K |
| DM | 2023-08-25 | 2023-08-23 | ANIP | Marken James G. | SVP OPS, PROD DEV | M - OptEx | $38.25 | -5,417 | 0 | -100% | -$207.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-23 | M | A | 1,667 | $33.00 | 137,044 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-23 | S | D | 3,932 | $63.00 | 133,112 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-23 | M | A | 3,750 | $40.59 | 135,377 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2023-08-23 | M | D | 3,750 | $40.59 | 0 | D | $40.59 · — to 2026-04-06 | 3,750 Common Stock | (F1) 25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020. |
| 5 | Derivative | Stock Option (right to buy) | 2023-08-23 | M | D | 1,667 | $33.00 | 0 | D | $33.00 · — to 2024-03-31 | 1,667 Common Stock | (F2) 25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018. |